SNHG3 and pachyonychia congenita: SNHG3 was also found at increased levels in prostate cancer tissues versus adjacent normal tissues (n = 26), indicating a potential association between SNHG3 and prostate cancer development, and further increased in PC/BM cases (n = 25) compared to PC/nBM cases (n = 35) from in-house clinical samples.